Mahalo DCT: Purpose-Built for Modern Trials
Decentralized Trials, Purpose-Built with Mahalo
AI-native. Patient-centric. Real-world-ready.
Mahalo's purpose-built platform for decentralized and hybrid trials combines patient-centric design with AI-powered infrastructure to accelerate recruitment, improve diversity, and enhance data quality.
Why Decentralized Clinical Trials?
DCTs are transforming clinical research by removing geographic barriers, improving patient diversity, and accelerating timelines.
3x Faster Recruitment
Remove geographic barriers to participation and reach a wider, more diverse patient population.
Read the research5x Increase in Patient Diversity
Engage underrepresented populations by eliminating travel and time barriers to participation.
View diversity data70% Fewer Site Visits
Reduce patient burden with remote assessments, virtual visits, and home-based procedures.
See the impactMahalo's DCT Infrastructure
Our purpose-built platform integrates every component needed for successful decentralized and hybrid trials.
How It Works
From screening to real-time analytics, Mahalo's DCT platform streamlines the entire trial journey.
Patient Journey in a Mahalo DCT
Adaptive Visits
Flexible visit scheduling that adapts to patient needs, combining virtual and in-person options.
Home-Based Engagement
Remote assessments, home nursing visits, and direct-to-patient drug shipments.
Real-Time Alerts
AI-powered monitoring with automated alerts for adverse events and compliance issues.
Use Case Grid
Mahalo's DCT platform adapts to the unique requirements of different therapeutic areas.
Patient Experience
Designed with patients at the center, Mahalo's DCT platform creates a seamless, engaging experience.
"As someone with a rare condition, participating in clinical trials used to be impossible due to travel. With Mahalo's platform, I was able to join a study from home with minimal disruption to my life."
Jessica M.
Rare Disease Trial Participant
"The virtual visits and home nursing support made it possible for my father to participate in an Alzheimer's trial. The technology was surprisingly easy to use, even for someone his age."
Robert T.
Caregiver for Cognitive Health Trial
Compare Trial Models
See how different trial approaches compare across key metrics and capabilities.
| Capability | Traditional Site-Based | Hybrid Model | Fully Decentralized |
|---|---|---|---|
| Patient Recruitment Speed | Slow | Moderate | Fast |
| Geographic Reach | Limited | Extended | Global |
| Patient Diversity | Low | Moderate | High |
| Patient Burden | High | Moderate | Low |
| Data Quality | Variable | Good | Excellent |
| Real-World Evidence | Limited | Moderate | Extensive |
Ready to Design Your Decentralized Trial?
Whether you're planning a fully virtual study or a hybrid approach, Mahalo's platform provides the flexibility, security, and patient-centricity you need.
